Buradasınız

STRONGYLOIDES STERCORALIS HYPERINFECTION IN AN IATROGENICALLY IMMUNOSUPPRESSED PATIENT: A CASE REPORT

Journal Name:

Publication Year:

DOI: 
10.5958/j.2319-5886.2.3.050
Abstract (2. Language): 
We report a case of Strongyloides stercoralis infection of the stomach in an elderly male patient who was on corticosteroids for six months. The patient presented with epigastric pain associated loss of appetite and loss of weight. The patient underwent upper endoscopy, and his gastric antral biopsy showed superficial ulcerations of the gastric mucosa with adult worms of Strongyloides stercoralis in the crypts of the gastric antrum. Stool sample showed the larval forms of Strongyloides. The patient was treated with Ivermectin in a dose of 200μg/kg/day PO for two days, same treatment was repeated after two weeks. Prednisone was tapered and stopped.
FULL TEXT (PDF): 
662-665

REFERENCES

References: 

1. Albonico M, Crompton DWT, and Savioli L.
Control strategies for human intestinal
nematode infections. Advancesin
Parasitology. 1998;42:277–341
2. Asdamongkol N, Pornsuriyasak P,
Sungkanuparph S. Risk factors for
strongyloidiasis hyperinfection and clinical
outcomes. Southeast Asian J Trop Med
Public Health. Sep 2006;37(5):875-84
665
Shafiq et al., Int J Med Res Health Sci. 2013;2(3):662-665
3. Fardet L, Généreau T, Poirot JL, Guidet B,
Kettaneh A, Cabane J. Severe
strongyloidiasis in corticosteroid-treated
patients: case series and literature review. J
Infect. Jan 2007;54(1):18-27.
4. Neefe LI, Pinilla O, Garagusi VF, and Bauer
H. Disseminated strongyloidiasis with
cerebral involvement: a complication of
corticosteroid therapy. The American
Journalof Medicine.1973; 55(6): 832–38
5. Jamil SAand Hilton E. The Strongyloides
hyperinfection syndrome. N. Y. St. J.
Med.1992; 92:67–68.
6. Gann PH, Neva FA, and Gam AA. A
randomized trial of singleand two-dose
ivermectin versus thiabendazole for treatment
of strongyloidiasis. J. Infect. Dis.
1994;169:1076–79.
7. Guzzo CA, Furtek CI, Porras AG. Safety,
tolerability, and pharmacokinetics of
escalating high doses of ivermectin in healthy
adult subjects. The Journal of Clinical
Pharmacology. 2002;42(10): 1122–33.
8. Datry A, Hilmarsdottir I, Mayorga-
Sagastume R, Lyagoubi M, Gaxotte P,
Biligui S, et al. Treatment of Strongyloides
stercoralis infection with ivermectin
compared with albendazole: results of an
open study of 60 cases. Trans R Soc Trop
Med Hyg. 1994;88(3):344-45.
9. Steinmann P, Zhou XN, Du ZW, Jiang JY,
Xiao SH, Wu ZX, et al. Tribendimidine and
albendazole for treating soil-transmitted
helminths, Strongyloides stercoralis and
Taenia spp: open-label randomized trial.
PLoS Negl Trop Dis. 2008;2(10):322
10. Boulware DR, Stauffer WM, Hendel-
Paterson BR, Rocha JL, Seet RC, Summer
AP. Maltreatment of Strongyloides infection:
case series and worldwide physicians-intraining
survey. Am J Med. Jun
2007;120(6):545-8

Thank you for copying data from http://www.arastirmax.com